About
Daniel Guinart, MD, is affiliated with the Division of Psychiatry Research at Zucker Hillside Hospital, Northwell Health, and the Institute for Behavioral Science at the Feinstein Institute for Medical Research in New York, as well as the Department of Psychiatry at Zucker School of Medicine at Northwell/Hofstra and research institutions in Barcelona, Spain. Guinart has published on topics related to schizophrenia and schizoaffective disorders, focusing on antipsychotic treatment strategies, including reasons for switching antipsychotic medications, outcomes associated with neuroleptic malignant syndrome from different antipsychotic formulations, and the practice of antipsychotic polypharmacy. The author has collaborated frequently with Christoph U. Correll, John M. Kane, Fuminari Misawa, Georgios Schoretsanitis, and Harshit Sharma.
